In parallel, we showed that this antagonist led to a lower vessel density and decreased infiltration of microglia/macrophages with a consecutive tumor volume reduction using an immunocompetent GBM rodent model focusing on the CXCL2/CXCR2 signaling pathway due to lacking the IL8 expression in mice [21]. This evidence concerns the gene CXCL8 and neoplasm.